Built for healing.
Designed for
hospitals.
A regenerative-medicine platform engineered to support clinical use and seamless integration into hospital systems.
Why Hospitals Choose Arvix
Regulatory Alignment
Developed with a clear regulatory framework and documentation approach that supports institutional review and approval.
Product Consistency
Placental-derived matrices engineered for structural integrity, reproducibility, and predictable clinical handling.
Economic Clarity
A focused portfolio designed to support evaluation, contracting, and adoption within hospital systems.
Arvix BioMatrix™ Platform
The Arvix BioMatrix™ Platform is a focused portfolio of placental-derived matrices developed within a unified regulatory and quality framework—designed to support predictable clinical handling and institutional adoption.
BioMatrix™ Core
A placental-derived amniotic membrane matrix designed to support regenerative care with consistency, integrity, and institutional readiness.
BioMatrix™ Base
A foundational amniotic membrane offering within the BioMatrix platform, designed for broad clinical applicability and hospital use.
VAC-Ready by Design
Developed with institutional review and adoption in mind.
Arvix products are designed to align with hospital evaluation processes, from documentation review through ordering activation. Our team supports institutional stakeholders by providing clear regulatory positioning, responsive clarification during review, and continuity through onboarding and implementation.
Download Product OverviewHCT/P 361 positioning
Traceability documentation
UDI-ready labeling
Processing transparency
Economic perspective
Hospital procurement decisions involve multiple considerations. Arvix provides documentation designed to support value analysis without making cost or outcome claims.
Procurement Efficiency
Standardized product portfolio and documentation designed to streamline hospital review and contracting processes.
Standardization Potential
Platform approach enables hospitals to evaluate multiple tissue configurations within a single regulatory and quality framework.
Documentation Support
Comprehensive materials addressing regulatory status, processing methods, and quality controls to facilitate committee evaluation.
Long-Term Planning
Consistent supply and quality systems designed to support ongoing hospital relationships and clinical program development.
Clinical Perspectives
The documentation package provided clear regulatory positioning and processing details that helped our value analysis committee understand the product category and quality controls. The materials addressed our standard review questions efficiently.
Dr. Sarah Mitchell
Director of Surgical Services, Regional Medical Center
Having a single platform with consistent processing standards simplified our procurement evaluation. The traceability documentation and quality system overview aligned well with our hospital's requirements for tissue-based products.
James Chen
Supply Chain Director, University Hospital System